Longeveron获欧洲药品管理局授予中小企业资格

美股速递
Jun 09

Longeveron Inc 已成功获得欧洲药品管理局(EMA)授予的中小企业(SME)资格。这一认定标志着公司在欧洲监管框架内获得了重要的官方身份认可,有望为其在欧洲市场的研发与商业化活动带来实质性支持与便利。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10